Somatic non-cancerous overgrowth syndrome of obscure molecular etiology: what are the causes and options?

Autor: Garneau AP; Nephrology Research Group, Department of Medicine, Faculty of Medicine, L'Hôtel-Dieu de Québec du CHU de Québec, Laval University, Quebec City, Québec, G1R 2J6, Canada.; Unité d'hypercroissance dysharmonieuse, Hôpital Necker-Enfants Malades, AP-HP, Inserm U1151, Université de Paris, rue de Sèvres, 75105, Paris, France., Haydock L; Nephrology Research Group, Department of Medicine, Faculty of Medicine, L'Hôtel-Dieu de Québec du CHU de Québec, Laval University, Quebec City, Québec, G1R 2J6, Canada., Tremblay LE; Nephrology Research Group, Department of Medicine, Faculty of Medicine, L'Hôtel-Dieu de Québec du CHU de Québec, Laval University, Quebec City, Québec, G1R 2J6, Canada., Harvey-Michaud PL; Nephrology Research Group, Department of Medicine, Faculty of Medicine, L'Hôtel-Dieu de Québec du CHU de Québec, Laval University, Quebec City, Québec, G1R 2J6, Canada., Hsiao YE; Fulgent Genetics, Temple City, CA, 91780, USA., Strom SP; Fulgent Genetics, Temple City, CA, 91780, USA., Canaud G; Unité d'hypercroissance dysharmonieuse, Hôpital Necker-Enfants Malades, AP-HP, Inserm U1151, Université de Paris, rue de Sèvres, 75105, Paris, France., Isenring P; Nephrology Research Group, Department of Medicine, Faculty of Medicine, L'Hôtel-Dieu de Québec du CHU de Québec, Laval University, Quebec City, Québec, G1R 2J6, Canada. paul.isenring@crhdq.ulaval.ca.
Jazyk: angličtina
Zdroj: Journal of molecular medicine (Berlin, Germany) [J Mol Med (Berl)] 2022 Jul; Vol. 100 (7), pp. 1087-1090. Date of Electronic Publication: 2022 Jun 03.
DOI: 10.1007/s00109-022-02214-2
Databáze: MEDLINE
Externí odkaz: